CHG Dressings in Children With Central Lines
| Status: | Recruiting |
|---|---|
| Healthy: | No |
| Age Range: | Any - 18 |
| Updated: | 4/21/2016 |
| Start Date: | February 2014 |
| End Date: | January 2018 |
| Contact: | John S Giuliano Jr, MD |
| Email: | john.giuliano@yale.edu |
| Phone: | 203-785-4651 |
Unit Based Comparison of Non- Versus Chlorhexidine-Impregnated Central Line Dressings
The purpose of this study is to determine whether Tegaderm CHG clear dressing reduces the
number of unscheduled central catheter dressing changes compared to standard clear Tegaderm
IV dressing in pediatric patients between the ages of 2 months to 18 years with central
venous access. Secondarily, we will monitor contact skin irritation and central line
associated blood stream infections.
number of unscheduled central catheter dressing changes compared to standard clear Tegaderm
IV dressing in pediatric patients between the ages of 2 months to 18 years with central
venous access. Secondarily, we will monitor contact skin irritation and central line
associated blood stream infections.
In this prospective, randomized, cohort study, we plan on enrolling all patients 2 months to
18 years of age admitted with a central venous catheter expected to be in place for > 48
hours. Patients will be randomized to either receive 1) Tegaderm CHG clear dressing or 2)
standard clear Tegaderm IV dressing. All central line care will remain uniform between the
two groups as dictated by the central line maintenance bundle currently directing central
line care in our children's hospital. Study completion will occur at the time of central
line removal or discharge from the hospital, whichever comes first.
18 years of age admitted with a central venous catheter expected to be in place for > 48
hours. Patients will be randomized to either receive 1) Tegaderm CHG clear dressing or 2)
standard clear Tegaderm IV dressing. All central line care will remain uniform between the
two groups as dictated by the central line maintenance bundle currently directing central
line care in our children's hospital. Study completion will occur at the time of central
line removal or discharge from the hospital, whichever comes first.
Inclusion Criteria:
- All patients 2 months to 18 years of age admitted with a central venous catheter
expected to be in place for > 48 hours.
Exclusion Criteria:
- Patients with known allergies to chlorhexidine or Tegaderm and those previously
enrolled in this study will be excluded.
- Patients with portacatheters
We found this trial at
1
site
New Haven, Connecticut 6520
(203) 432-4771
Principal Investigator: John S Giuliano Jr, MD
Phone: 203-785-4651
Yale University Yale's roots can be traced back to the 1640s, when colonial clergymen led...
Click here to add this to my saved trials
